AU2016900442A0 - PAK1-blocking esters, preparation, and their use in treatment of cancer and other PAK1-dependent diseases/disorders - Google Patents

PAK1-blocking esters, preparation, and their use in treatment of cancer and other PAK1-dependent diseases/disorders

Info

Publication number
AU2016900442A0
AU2016900442A0 AU2016900442A AU2016900442A AU2016900442A0 AU 2016900442 A0 AU2016900442 A0 AU 2016900442A0 AU 2016900442 A AU2016900442 A AU 2016900442A AU 2016900442 A AU2016900442 A AU 2016900442A AU 2016900442 A0 AU2016900442 A0 AU 2016900442A0
Authority
AU
Australia
Prior art keywords
pak1
disorders
cancer
preparation
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016900442A
Inventor
Pham Thi BE TU
Hiroshi Maruta
Binh Cao Quan NGUYEN
Hideaki Takahashi
Shinkichi Tawata
Yoshihiro Uto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2016900442A0 publication Critical patent/AU2016900442A0/en
Priority to US15/364,416 priority Critical patent/US10058618B2/en
Abandoned legal-status Critical Current

Links

AU2016900442A 2016-02-10 2016-02-10 PAK1-blocking esters, preparation, and their use in treatment of cancer and other PAK1-dependent diseases/disorders Abandoned AU2016900442A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US15/364,416 US10058618B2 (en) 2016-02-10 2016-11-30 PAK1-blocking 1,2,3-triazolyl esters

Publications (1)

Publication Number Publication Date
AU2016900442A0 true AU2016900442A0 (en) 2016-02-25

Family

ID=

Similar Documents

Publication Publication Date Title
HUE049237T2 (en) Compositions for use in methods for the treatment of wounds, disorders, and diseases of the skin
EP3668497A4 (en) Methods and compositions for the treatment of diseases associated with cancer, inflammation, or immune response
EP3471735A4 (en) Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases
EP3448398A4 (en) Compositions and methods for treatment of skin disorders
EP3137116A4 (en) Dendrimer compositions and their use in treatment of diseases of the eye
EP3454858A4 (en) Combination treatment of ocular inflammatory disorders and diseases
EP3337465A4 (en) Compositions and methods for use in combination for the treatment and diagnosis of autoimmune diseases
EP3160493A4 (en) Compositions and methods to regulate renalase in the treatment of diseases and disorders
EP3268007A4 (en) Compositions and therapeutic methods for the treatment of complement-associated diseases
EP3405215A4 (en) Methods for the treatment of danon disease and other disorders of autophagy
EP3538119A4 (en) Compositions and methods for treating skin diseases and maintaining healthy skin
EP3344632A4 (en) Heterobicyclic pyrimidinone compounds and their use in the treatment of medical disorders
EP3565607A4 (en) Fusogenic lipid nanoparticles and methods for manufacturing and use for therapeutic protein production and for treatment
EP3215510A4 (en) Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders
EP3151829A4 (en) Novel sesquiterpene derivatives and their use in inflammation and cancer treatment
EP3290034A4 (en) Use of trimethazine in preparation of drugs for preventing and treating liver diseases
EP3464378A4 (en) Methods for the use of cd32b x cd79b-binding molecules in the treatment of inflammatory diseases and disorders
EP3169321A4 (en) Propolis and extracts thereof for the treatment of skin cancers and improvement of skin health
EP3481958A4 (en) Methods and compositions for treatment of disorders and diseases involving rdh12
EP3488850A4 (en) Novel application of gzd824 and pharmaceutically acceptable salts thereof in treating diseases
EP3326637A4 (en) Use of mangosteen rind extract in preparation of medicine for treating skin diseases
EP3534918A4 (en) Exosomes and uses thereof in diseases of the brain
EP2999479A4 (en) Human monocyte sub-population for treatment of eye diseases and disorders
EP3344233A4 (en) Transdermal formulations for delivery of doxycycline, and their use in the treatment of doxycycline-responsive diseases and conditions
EP3119387A4 (en) Compositions for the treatment of dermatological diseases and disorders